Cargando…

Learning Biomarker Models for Progression Estimation of Alzheimer’s Disease

Being able to estimate a patient’s progress in the course of Alzheimer’s disease and predicting future progression based on a number of observed biomarker values is of great interest for patients, clinicians and researchers alike. In this work, an approach for disease progress estimation is presente...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt-Richberg, Alexander, Ledig, Christian, Guerrero, Ricardo, Molina-Abril, Helena, Frangi, Alejandro, Rueckert, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838309/ https://www.ncbi.nlm.nih.gov/pubmed/27096739 http://dx.doi.org/10.1371/journal.pone.0153040

Ejemplares similares

Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database
por: Ledig, Christian, et al.
Publicado: (2018)

Brain Extraction Using Label Propagation and Group Agreement: Pincram
por: Heckemann, Rolf A., et al.
Publicado: (2015)

Correction: Brain Extraction Using Label Propagation and Group Agreement: Pincram
por: Heckemann, Rolf A., et al.
Publicado: (2015)

Understanding the need of ventricular pressure for the estimation of diastolic biomarkers
por: Xi, Jiahe, et al.
Publicado: (2013)

Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
por: Di Marco, Luigi Yuri, et al.
Publicado: (2015)

Resolving degeneracy in diffusion MRI biophysical model parameter estimation using double diffusion encoding
por: Coelho, Santiago, et al.
Publicado: (2019)

Volume Change in Frontal Cholinergic Structures After Traumatic Brain Injury and Cognitive Outcome
por: Östberg, Anna, et al.
Publicado: (2020)

Molecular biomarkers of Alzheimer's disease: progress and prospects
por: Lashley, Tammaryn, et al.
Publicado: (2018)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
por: Huang, Shan, et al.
Publicado: (2022)

Differential diagnosis of neurodegenerative diseases using structural MRI data
por: Koikkalainen, Juha, et al.
Publicado: (2016)

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
por: Alexopoulos, Panagiotis, et al.
Publicado: (2016)

Transfer learning‐trained convolutional neural networks identify novel MRI biomarkers of Alzheimer's disease progression
por: Li, Yi, et al.
Publicado: (2021)

Algorithmic Fairness of Machine Learning Models for Alzheimer Disease Progression
por: Yuan, Chenxi, et al.
Publicado: (2023)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease()
por: Archetti, Damiano, et al.
Publicado: (2019)

Reduced Order Modeling of Nonlinear Vibrating Multiphysics Microstructures with Deep Learning-Based Approaches
por: Gobat, Giorgio, et al.
Publicado: (2023)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial
por: Abril-Molina, Ana, et al.
Publicado: (2020)

Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
por: Tong, Tong, et al.
Publicado: (2017)

Estimating effective connectivity in Alzheimer's disease progression: A dynamic causal modeling study
por: Huang, Jiali, et al.
Publicado: (2022)

A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
por: McGhee, David J. M., et al.
Publicado: (2014)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
por: Cullen, Nicholas C., et al.
Publicado: (2020)

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
por: Varesi, Angelica, et al.
Publicado: (2022)

Blood Analytes as Biomarkers of Mechanisms Involved in Alzheimer’s Disease Progression
por: Baldini, Andrea, et al.
Publicado: (2022)

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Anticipated reactions to learning Alzheimer’s disease biomarker results
por: Clark, Lindsay R., et al.
Publicado: (2022)

Dynamic feature learning for COVID-19 segmentation and classification
por: Zhang, Xiaoqin, et al.
Publicado: (2022)

Medical imaging deep learning with differential privacy
por: Ziller, Alexander, et al.
Publicado: (2021)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Machine learning for comprehensive forecasting of Alzheimer’s Disease progression
por: Fisher, Charles K., et al.
Publicado: (2019)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers
por: Hooper, Claudie, et al.
Publicado: (2008)

Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma
por: Frood, Russell, et al.
Publicado: (2022)

Development and validation of immune-based biomarkers and deep learning models for Alzheimer’s disease
por: He, Yijie, et al.
Publicado: (2022)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage
por: Poil, Simon-Shlomo, et al.
Publicado: (2013)

Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression
por: Javaid, Fatimah Zara, et al.
Publicado: (2016)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
por: Ahmad, Shahzad, et al.
Publicado: (2020)

Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer’s Disease Progression
por: Nam, Eunjoo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ov3sqigpjnj2344nabftu4sjqa